Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Hepatogastroenterology ; 54(76): 1161-3, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17629061

RESUMO

A case of the isolated dissection of the superior mesenteric artery (SMA) is presented, with the intravascular ultrasound (IVUS) images. Abdominal computed tomography revealed an intraluminal hematoma in the proximal portion of the SMA in a 57-year-old man complaining of persistent abdominal pain. Selective angiography showed narrowing of the SMA. The most compatible diagnosis was a dissection of the SMA, however, the possibility of SMA thromboembolisms could not be denied. Transcatheter suction removal of thrombi would be reconmmended for SMA thromboembolisms, however, intraarterial suction should be avoided so as not to injure the internal surface of the intima in cases of dissection of SMA. The IVUS images clearly demonstrated the condition of the true and false lumen of the dissecting region in detail. Transluminal balloon angioplasty of the true lumen and systemic anticoagulation treatment resulted in uneventful recovery. Demonstration of the exact condition in the dissecting region using IVUS is useful for selecting therapeutic strategies in cases with isolated dissecting aneurysm of the SMA.


Assuntos
Dissecção Aórtica/diagnóstico por imagem , Artéria Mesentérica Superior/diagnóstico por imagem , Ultrassonografia/métodos , Dissecção Aórtica/terapia , Humanos , Masculino , Pessoa de Meia-Idade
2.
Am J Clin Nutr ; 75(1): 112-8, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11756068

RESUMO

BACKGROUND: There are no accurate indexes for determining the status of manganese in humans, and there is no clear recommended daily dose of this essential trace element to be administered in total parenteral nutrition solutions. OBJECTIVE: The objectives were to evaluate accurate indexes of manganese status and elucidate the optimal manganese dose to be administered to adult patients undergoing home parenteral nutrition. DESIGN: Patients were administered total parenteral nutrition solutions providing 0, 1, 2, or 20 micromol Mn/d according to an on-off design, after which manganese concentrations in whole blood and plasma were determined. Magnetic resonance imaging (MRI) was performed to determine the intensity on T(1)-weighted images (MRI intensity) and T(1) values in the globus pallidus. Hematologic and biochemistry tests were also performed. RESULTS: High degrees of correlation were found between whole-blood manganese concentrations and both MRI intensity (r = 0.7728) and T(1) values (r = -0.7519) in the globus pallidus. A strong negative correlation was found between MRI intensity and T(1) values (r = -0.8407). The dose of 1 micromol Mn/d caused no change in MRI intensity or T(1) values, and the whole-blood manganese concentration remained within the normal range in all patients. CONCLUSIONS: Whole-blood manganese concentrations and MRI intensity and T(1) values in the globus pallidus are useful indexes of the status of manganese in humans. The optimal dose of manganese may be 1 micromol/d for adult patients undergoing home parenteral nutrition.


Assuntos
Manganês/sangue , Estado Nutricional , Nutrição Parenteral no Domicílio , Adolescente , Adulto , Encéfalo/metabolismo , Feminino , Humanos , Injeções Intravenosas , Imageamento por Ressonância Magnética , Masculino , Manganês/administração & dosagem , Pessoa de Meia-Idade
3.
Gan To Kagaku Ryoho ; 31(12): 2047-9, 2004 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-15570938

RESUMO

A 79-year-old man was admitted for advanced transverse colon cancer with large bowel obstruction. Twelve years earlier he underwent a total gastrectomy with Roux-en Y reconstruction for gastric cancer. No metastasis was detected preoperatively. Exploratory laparotomy revealed massive direct invasion of the mesenterium of the jejunum for Roux-en Y reconstruction. The primary lesion was unresected and transverse colostomy was made. Systemic chemotherapy with 5-fluorouracil and l-leucovorin was scheduled for a total of 4 courses postoperatively. After completion of this chemotherapeutic regimen, a CT scan and colonofiberscopy revealed the primary lesions had disappeared, and a histological examination of biopsy confirmed that the patient had achieved a complete remission (CR). There was no severe side effect during chemotherapy. The patient is presently enjoying a good general condition and has been free from any sign of recurrence.


Assuntos
Adenocarcinoma/tratamento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias do Colo/tratamento farmacológico , Adenocarcinoma/patologia , Adenocarcinoma/cirurgia , Idoso , Neoplasias do Colo/patologia , Neoplasias do Colo/cirurgia , Colostomia , Terapia Combinada , Esquema de Medicação , Fluoruracila/administração & dosagem , Humanos , Leucovorina/administração & dosagem , Masculino , Invasividade Neoplásica
4.
Masui ; 53 Suppl: S102-10, 2004 Dec.
Artigo em Japonês | MEDLINE | ID: mdl-15672740
5.
Surg Today ; 33(8): 600-5, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12884098

RESUMO

PURPOSE: Dietary fortification of n-9 polyunsaturated fatty acids (PUFA) or 5,8,11-eicosatrienoic acid (ETrA) as well as n-3 PUFA might contribute to the suppression of leukotriene B4 (LTB4) synthesis and thereby reduce inflammatory bowel lesions. As a result, the effect of an ETrA-enriched diet on experimental bowel lesions was examined in this study. METHODS: In Expt. 1, rats were freely fed either an ETrA-enriched or a standard diet. After 7 days of feeding, acute bowel lesions were induced by the subcutaneous injection of 10 mg/kg indomethacin. In Expt. 2, chronic bowel lesions were made by performing subcutaneous injections of 7.5 mg/kg indomethacin twice. After the first injection, the rats were freely fed either an ETrA-enriched or a standard diet for 7 days. RESULTS: In both experiments, the rats fed an ETrA-enriched diet showed increased levels of ETrA in the plasma and intestinal mucosa, and a decreased inflammation score. However, there was no significant decrease in plasma and intestinal mucosal LTB4 in the ETrA-enriched diet-fed rats. CONCLUSION: These results suggest that the dietary supplementation of ETrA may have both prophylactic and therapeutic effects on experimentally produced bowel lesions. Further investigations are necessary to clarify the effects of ETrA on bowel lesions and its mechanisms.


Assuntos
Ácido 8,11,14-Eicosatrienoico/análogos & derivados , Ácido 8,11,14-Eicosatrienoico/farmacologia , Doenças Inflamatórias Intestinais/etiologia , Animais , Dieta , Indometacina , Doenças Inflamatórias Intestinais/dietoterapia , Intestinos/efeitos dos fármacos , Leucotrieno B4/metabolismo , Masculino , Ratos , Ratos Sprague-Dawley
6.
Pediatr Transplant ; 6(3): 235-9, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12100509

RESUMO

It has not been fully determined whether isolated small bowel transplantation (ISBTx) can reverse liver dysfunction caused by intestinal failure requiring long-term total parenteral nutrition (TPN). A boy with congenital microvillus inclusion disease presented with vomiting and severe diarrhea since the first day of life and had been managed by TPN since then. He suffered from catheter-related sepsis several times. At 14 yr of age he developed progressive hepatosplenomegaly with thrombocytopenia and coagulopathy. He underwent ISBTx with an ileal graft from his blood-identical grandmother at the age of 16 yr. Oral feeding was started on the 14th day after ISBTx and gradually increased. TPN was completely withdrawn after 5 months. Liver was palpated 5 cm below the costal margin before ISBTx, while it became non-palpable 5 months after ISBTx. Serum liver enzyme levels and prothrombin time normalized in the 5 months following ISBTx. Liver biopsy showed marked steatosis, slight cholestasis, and mild bridging fibrosis before ISBTx. Although histological examination of liver biopsy revealed complete disappearance of steatosis 7 and 11 months after ISBTx, liver fibrosis remained unchanged. This clinical experience has shown that although steatosis and cholestasis are reversible after successful ISBTx and withdrawal of TPN, liver fibrosis may remain unchanged.


Assuntos
Enteropatias/terapia , Intestino Delgado/transplante , Hepatopatias/cirurgia , Nutrição Parenteral Total/efeitos adversos , Adolescente , Humanos , Corpos de Inclusão/patologia , Enteropatias/congênito , Cirrose Hepática/etiologia , Cirrose Hepática/patologia , Hepatopatias/etiologia , Hepatopatias/patologia , Masculino , Microvilosidades/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA